Beauty Farm Medical and Health Industry Inc. (Beauty Farm Med) reported that it repurchased 413,500 ordinary shares on the Hong Kong Stock Exchange during September 2026, according to its monthly return filed on 6 October 2026. All repurchased shares were retained as treasury stock, reducing the number of shares in public hands while keeping overall issued share capital unchanged at 251.59 million shares.

At 31 August 2026, Beauty Farm Med had 248.06 million issued shares (excluding 3.53 million treasury shares). Following the September buy-backs, outstanding shares fell to 247.65 million, and treasury shares rose to 3.95 million—equivalent to 1.57% of total issued shares. The repurchased amount represents approximately 0.17% of shares outstanding at the start of the month.

The company executed 15 on-market repurchase transactions between 1 September and 30 September 2026, paying prices between HK$17.52 and HK$19.22 per share. Aggregate outlay for the month totalled roughly HK$7.61 million, implying an average buy-back price of about HK$18.41.

Authorised share capital remained unchanged at 10 billion ordinary shares with a par value of USD 0.000005 each, translating to total authorised capital of USD 50,000.

Beauty Farm Med confirmed that it continued to meet the Hong Kong Stock Exchange’s minimum 25% public-float requirement as at 30 September 2026. The filing also states that no share options, warrants, convertibles or other equity-linked instruments were issued or outstanding during the period.